UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer

Cancer Genetics and Cytogenetics

Volumn 196, Issue 1, 2010, Pages 45-55

  Yang, Youfeng ^a   Valera, Vladimir A ^a   Padilla Nash, Hesed M ^a   Sourbier, Carole ^a   Vocke, Cathy D ^a   Vira, Manish A ^a   Abu Asab, Mones S ^a   Bratslavsky, Gennady ^a   Tsokos, Maria ^a   Merino, Maria J ^a   Pinto, Peter A ^a   Srinivasan, Ramaprasad ^a   Ried, Thomas ^a   Neckers, Len ^a   Linehan, W Marston ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUMARATE HYDRATASE; GLUCOSE; GLUCOSE TRANSPORTER 1; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME 5; LACTIC ACID; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG;

ADULT; ANAEROBIC GLYCOLYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CATABOLISM; CATALYSIS; CELL INVASION; CELL STRUCTURE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; ENERGY METABOLISM; ENZYME DEFICIENCY; ENZYME LOCALIZATION; EXON; GENE EXPRESSION; GLUCOSE TRANSPORT; HEREDITARY LEIOMYOMATOSIS RENAL CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; ISOCHROMOSOME; KIDNEY CARCINOMA; MALE; MITOCHONDRION; MOUSE; MUTANT; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL LINE; ENERGY METABOLISM; FUMARATE HYDRATASE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; LEIOMYOMATOSIS; MICE; MICE, NUDE; MODELS, BIOLOGICAL;

EID: 70949105507     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.08.018     Document Type: Article

References (37)

1. Fernández-Pugnaire M.A., and Delgado-Florencio V. Familial multiple cutaneous leiomyomas. Dermatology 191 (1995) 295-298
2. Zbar B., Glenn G., Lubensky I., Choyke P., Walther M.M., Magnusson G., Bergerheim U.S., Pettersson S., Amin M., and Hurley K. Hereditary papillary renal cell carcinoma: clinical studies in 10 families. J Urol 153 (1995) 907-912
3. Launonen V., Vierimaa O., Kiuru M., Isola J., Roth S., Pukkala E., Sistonen P., Herva R., and Aaltonen L.A. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A 98 (2001) 3387-3392
4. Tomlinson I.P., Alam N.A., Rowan A.J., Barclay E., Jaeger E.E., Kelsell D., Leigh I., Gorman P., Lamlum H., Rahman S., Roylance R.R., Olpin S., Bevan S., Barker K., Hearle N., Houlston R.S., Kiuru M., Lehtonen R., Karhu A., Vilkki S., Laiho P., Eklund C., Vierimaa O., Aittomäki K., Hietala M., Sistonen P., Paetau A., Salovaara R., Herva R., Launonen V., and Aaltonen L.A. Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30 (2002) 406-410
5. Kiuru M., Lehtonen R., Arola J., Salovaara R., Järvinen H., Aittomäki K., Sjöberg J., Visakorpi T., Knuutila S., Isola J., Delahunt B., Herva R., Launonen V., Karhu A., and Aaltonen L.A. Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. Cancer Res 62 (2002) 4554-4557
6. Grubb III R.L., Franks M.E., Toro J., Middelton L., Choyke L., Fowler S., Torres-Cabala C., Glenn G.M., Choyke P., Merino M.J., Zbar B., Pinto P.A., Srinivasan R., Coleman J.A., and Linehan W.M. Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 177 (2007) 2074-2079
7. Kiuru M., Launonen V., Hietala M., Aittomäki K., Vierimaa O., Salovaara R., Arola J., Pukkala E., Sistonen P., Herva R., and Aaltonen L.A. Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol 159 (2001) 825-829
8. Merino M.J., Torres-Cabala C., Pinto P., and Linehan W.M. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 31 (2007) 1578-1585
9. Isaacs J.S., Jung Y.J., Mole D.R., Lee S., Torres-Cabala C., Chung Y.L., Merino M., Trepel J., Zbar B., Toro J., Ratcliffe P.J., Linehan W.M., and Neckers L. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8 (2005) 143-153
10. Pollard P.J., Brière J.J., Alam N.A., Barwell J., Barclay E., Wortham N.C., Hunt T., Mitchell M., Olpin S., Moat S.J., Hargreaves I.P., Heales S.J., Chung Y.L., Griffiths J.R., Dalgleish A., McGrath J.A., Gleeson M.J., Hodgson S.V., Poulsom R., Rustin P., and Tomlinson I.P. Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14 (2005) 2231-2239
11. Matyakhina L., Freedman R.J., Bourdeau I., Wei M.H., Stergiopoulos S.G., Chidakel A., Walther M., Abu-Asab M., Tsokos M., Keil M., Toro J., Linehan W.M., and Stratakis C.A. Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: a clinical and molecular genetic investigation. J Clin Endocrinol Metab 90 (2005) 3773-3779
12. Alam N.A., Olpin S., and Leigh I.M. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol 153 (2005) 11-17
13. Wei M.H., Toure O., Glenn G.M., Pithukpakorn M., Neckers L., Stolle C., Choyke P., Grubb R., Middelton L., Turner M.L., Walther M.M., Merino M.J., Zbar B., Linehan W.M., and Toro J.R. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 43 (2006) 18-27
14. Arany Z., Foo S.Y., Ma Y., Ruas J.L., Bommi-Reddy A., Girnun G., Cooper M., Laznik D., Chinsomboon J., Rangwala S.M., Baek K.H., Rosenzweig A., and Spiegelman B.M. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α. Nature 451 (2008) 1008-1012
15. Warburg O. On the origin of cancer cells. Science 123 (1956) 309-314
16. Anglard P., Trahan E., Liu S., Latif F., Merino M.J., Lerman M.I., Zbar B., and Linehan W.M. Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res 52 (1992) 348-356
17. Yang Y., Padilla-Nash H.M., Vira M.A., Abu-Asab M.S., Val D., Worrell R., Tsokos M., Merino M.J., Pavlovich C.P., Ried T., Linehan W.M., and Vocke C.D. The UOK 257 cell line: a novel model for studies of the human Birt-Hogg-Dubé gene pathway. Cancer Genet Cytogenet 180 (2008) 100-109
18. Shipley J.M., Birdsall S., Clark J., Crew J., Gill S., Linehan M., Gnarra J., Fisher S., Craig I.W., and Cooper C.S. Mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X;1)(p11.2;q21.2) and the first report of a female case. Cytogenet Cell Genet 71 (1995) 280-284
19. Sidhar S.K., Clark J., Gill S., Hamoudi R., Crew A.J., Gwilliam R., Ross M., Linehan W.M., Birdsall S., Shipley J., and Cooper C.S. The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 5 (1996) 1333-1338
20. Wu M., Neilson A., Swift A.L., Moran R., Tamagnine J., Parslow D., Armistead S., Lemire K., Orrell J., Teich J., Chomicz S., and Ferrick D.A. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292 (2007) C125-C136
21. Padilla-Nash H.M., Barenboim-Stapleton L., Difilippantonio M.J., and Ried T. Spectral karyotyping analysis of human and mouse chromosomes. Nat Protoc 1 (2006) 3129-3142
22. In: Shaffer L.G., and Tommerup N. (Eds). ISCN 2005: an international system for human cytogenetic nomenclature (2005) (2005), S. Karger, Basel
23. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid [Erratum in: Anal Biochem 1987;163:279]. Anal Biochem 150 (1985) 76-85
24. Hatch M.D. A simple spectrophotometric assay for fumarate hydratase in crude tissue extracts. Anal Biochem 85 (1978) 271-275
25. Singh B., and Gupta R.S. Mitochondrial import of human and yeast fumarase in live mammalian cells: retrograde translocation of the yeast enzyme is mainly caused by its poor targeting sequence. Biochem Biophys Res Commun 346 (2006) 911-918
26. Bowes T., Singh B., and Gupta R.S. Subcellular localization of fumarase in mammalian cells and tissues. Histochem Cell Biol 127 (2007) 335-346
27. Ferrick D.A., Neilson A., and Beeson C. Advances in measuring cellular bioenergetics using extracellular flux. Drug Discov Today 13 (2008) 268-274
28. Sudarshan S., Sourbier C., Kong H.S., Block K., Valera Romero V.A., Yang Y., Galindo C., Mollapour M., Scroggins B., Goode N., Lee M.J., Gourlay C.W., Trepel J., Linehan W.M., and Neckers L. Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1α stabilization by glucose-dependent generation of reactive oxygen species. Mol Cell Biol 29 (2009) 4080-4090
29. Warburg O., Posener K., and Negelein E. Metabolism of the carcinoma cell [In German]. Biochem Z 152 (1924) 309-344
30. Garber K. Energy deregulation: licensing tumors to grow. Science 312 (2006) 1158-1159
31. Shaw R.J. Glucose metabolism and cancer. Curr Opin Cell Biol 18 (2006) 598-608
32. Alam N.A., Rowan A.J., Wortham N.C., Pollard P.J., Mitchell M., Tyrer J.P., Barclay E., Calonje E., Manek S., Adams S.J., Bowers P.W., Burrows N.P., Charles-Holmes R., Cook L.J., Daly B.M., Ford G.P., Fuller L.C., Hadfield-Jones S.E., Hardwick N., Highet A.S., Keefe M., MacDonald-Hull S.P., Potts E.D., Crone M., Wilkinson S., Camacho-Martinez F., Jablonska S., Ratnavel R., MacDonald A., Mann R.J., Grice K., Guillet G., Lewis-Jones M.S., McGrath H., Seukeran D.C., Morrison P.J., Fleming S., Rahman S., Kelsell D., Leigh I., Olpin S., and Tomlinson I.P. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12 (2003) 1241-1252
33. Toro J.R., Nickerson M.L., Wei M.H., Warren M.B., Glenn G.M., Turner M.L., Stewart L., Duray P., Tourre O., Sharma N., Choyke P., Stratton P., Merino M., Walther M.M., Linehan W.M., Schmidt L.S., and Zbar B. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73 (2003) 95-106
34. Xie H., Valera V.A., Merino M.J., Amato A.M., Signoretti S., Linehan W.M., Sukhatme V.P., and Seth P. LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer. Mol Cancer Ther 8 (2009) 626-635
35. Mertens F., Johansson B., and Mitelman F. Isochromosomes in neoplasia. Genes Chromosomes Cancer 10 (1994) 221-230
36. In: Mitelman F., Johansson B., and Mertens F. (Eds). Catalog of chromosome aberrations in cancer. 5th ed (1994), Wiley-Liss, New York
37. Zhang J., Lindroos A., Ollila S., Russell A., Marra G., Mueller H., Peltomaki P., Plasilova M., and Heinimann K. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers. Cancer Res 66 (2006) 659-664